A research team led by University of Florida neuroscience graduate students has devised a new mouse model to study the protein tau, which can abnormally accumulate inside neurons and is associated with Alzheimer’s disease and related dementias.
Research by Adam J. Woods, Ph.D., associate director of UF’s Center for Cognitive Aging and Memory, and collaborators using artificial intelligence to personalize transcranial direct current stimulation (tDCS) was highlighted in the Society for Neuroscience’s 2021 annual report.
New mouse-model research by University of Florida neuroscientists provides fresh insight into the impact of elevated levels of the protein alpha-synuclein on the function of dopamine-producing nerve cells, the progressive demise of which is associated with Parkinson’s disease.
University of Florida neuroscientists have developed a new assay, or test, to detect minute amounts of a protein called tyrosine hydroxylase in blood immune cells of Parkinson’s disease patients, a key finding to aid in the development of a blood test to help diagnose and guide treatment for the neurodegenerative disorder.
Barry Setlow, Ph. D. and Jen Bizon, Ph.D. co-edit an invitational special issue of the Behavioural Brain Research journal titled “Amygdala and value-based decision making,” based on related previous work.
Emerald Health Pharmaceuticals Inc., a clinical-stage biotechnology company developing a new class of medicines to treat diseases with unmet medical needs, has expanded its Scientific Advisory Board with the appointment of University of Florida's neuroscience expert and innovator, Eduardo Candelario-Jalil, Ph.D.
Duane Mitchell’s team at the University of Florida is a world leader in understanding how the body’s own immune system can be marshaled to fight cancers, especially brain cancers, in children and adults.
The University of Florida has awarded 20 faculty teams $50,000 each from UF Research’s Artificial Intelligence Research Catalyst Fund to pursue a range of AI-related projects.